5-amino-1mq and cd38 inhibitor synergy nad+ Rapid Discovery of via DNA-Encoded Natural Product Library Screening The Pharmacology of CD38/NADase: An
The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC Nicotinamide N methyltransferase as a potential therapeutic target for neurodegenerative disorders: Mechanisms, challenges, and future directions ScienceDirect Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect New Insights on Muscle Strength: The Role of Inhibiting an Enzyme that Hinders NAD+ Synthesis A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline ScienceDirect
Pay in 4 interest-free payments of $5.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4




